CVSI CV Sciences, Inc. revenue, earnings and financials
For the quarter ended June 30, 2026, CV Sciences, Inc. reported revenue of $2.99M (down 17.5% from a year earlier), net income of −$775K and diluted EPS of $0.00; over the last four quarters revenue was $12.7M and net income −$2.01M; for the fiscal year ended December 2025 revenue was $13.8M, down 12.2% on the year before.
CVSI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $13.8M, gross profit $6.75M, operating income −$470K, net income −$958K (margin -6.9%), EPS −$0.01
- Fiscal year ended Dec 2024: revenue $15.7M, gross profit $7.17M, operating income −$2.19M, net income −$2.39M (margin -15.2%), EPS −$0.01
- Fiscal year ended Dec 2023: revenue $16.0M, gross profit $7.09M, operating income $3.36M, net income $3.10M (margin 19.4%), EPS $0.02
- Fiscal year ended Dec 2022: revenue $16.2M, gross profit $5.55M, operating income −$6.85M, net income −$8.21M (margin -50.7%), EPS −$0.07
- Fiscal year ended Dec 2021: revenue $20.0M, gross profit $8.62M, operating income −$18.4M, net income −$15.6M (margin -77.6%), EPS −$0.14
CVSI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.99M (down 17.5% year over year), net income −$775K, EPS $0.00
- Quarter ended Mar 31, 2026: revenue $3.20M (down 11.4% year over year), net income −$643K, EPS $0.00
- Quarter ended Dec 31, 2025 (from the annual report): revenue $3.31M (down 14.9% year over year), net income −$206K, EPS −$0.01
- Quarter ended Sep 30, 2025: revenue $3.26M (down 15.8% year over year), net income −$382K, EPS $0.00
- Quarter ended Jun 30, 2025: revenue $3.62M (down 8.4% year over year), net income −$261K, EPS $0.00
- Quarter ended Mar 31, 2025: revenue $3.61M (down 9.9% year over year), net income −$109K, EPS $0.00
- Quarter ended Dec 31, 2024 (from the annual report): revenue $3.88M (up 2.2% year over year), net income −$726K, EPS −$0.01
- Quarter ended Sep 30, 2024: revenue $3.87M (down 5.5% year over year), net income −$456K, EPS $0.00
- Quarter ended Jun 30, 2024: revenue $3.95M (down 0.3% year over year), net income −$584K, EPS $0.00
- Quarter ended Mar 31, 2024: revenue $4.00M (down 3.5% year over year), net income −$628K, EPS $0.00
- Quarter ended Dec 31, 2023 (from the annual report): revenue $3.80M (down 1.8% year over year), net income −$869K, EPS −$0.01
- Quarter ended Sep 30, 2023: revenue $4.09M (up 9.0% year over year), net income −$447K, EPS $0.00
- Quarter ended Jun 30, 2023: revenue $3.97M (down 4.2% year over year), net income −$1.29M, EPS −$0.01
- Quarter ended Mar 31, 2023: revenue $4.15M (down 6.7% year over year), net income $5.71M, EPS $0.04
- Quarter ended Dec 31, 2022 (from the annual report): revenue $3.87M (down 22.1% year over year), net income −$2.31M, EPS −$0.01
- Quarter ended Sep 30, 2022: revenue $3.75M (down 26.6% year over year), net income −$1.03M, EPS −$0.01
- Quarter ended Jun 30, 2022: revenue $4.14M (down 19.3% year over year), net income −$2.65M, EPS −$0.03
- Quarter ended Mar 31, 2022: revenue $4.45M (down 8.2% year over year), net income −$2.22M, EPS −$0.02
- Quarter ended Dec 31, 2021 (from the annual report): revenue $4.97M, net income −$8.86M, EPS −$0.08
- Quarter ended Sep 30, 2021: revenue $5.11M, net income −$40.0K, EPS $0.00
CVSI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$407K, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$861K, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow $2.25M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$1.89M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$7.49M, share buybacks n/a
CVSI balance sheet
- Jun 30, 2026: cash n/a, total assets $6.52M, total liabilities $4.95M, shareholders' equity $1.57M, long-term debt $0
- Mar 31, 2026: cash n/a, total assets $6.72M, total liabilities $5.22M, shareholders' equity $1.50M, long-term debt $0
- Dec 31, 2025: cash n/a, total assets $6.96M, total liabilities $5.49M, shareholders' equity $1.47M, long-term debt $387K
- Sep 30, 2025: cash n/a, total assets $7.00M, total liabilities $5.46M, shareholders' equity $1.54M, long-term debt $504K
- Jun 30, 2025: cash n/a, total assets $7.95M, total liabilities $6.15M, shareholders' equity $1.80M, long-term debt $208K
- Mar 31, 2025: cash n/a, total assets $7.76M, total liabilities $5.87M, shareholders' equity $1.89M, long-term debt $498K
- Dec 31, 2024: cash n/a, total assets $7.93M, total liabilities $6.13M, shareholders' equity $1.80M, long-term debt $0
- Sep 30, 2024: cash n/a, total assets $8.39M, total liabilities $6.20M, shareholders' equity $2.19M
What is CVSI's revenue?
CV Sciences, Inc. reported $12.7M of revenue over its last four quarters, through June 30, 2026.
Is CVSI profitable?
No. CV Sciences, Inc. lost $2.01M over the last four quarters.
What is CVSI's EPS?
Diluted earnings per share over the last four quarters were −$0.01; $0.00 in the latest quarter.